Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Distribution of Dapsone in Leucocytes
NCT02493283Phase 1Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Sep 2011
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of dapsone in autoimmune bullous dermatoses and Linear IgA bullous dermatosis (LABD) (2 arms), sponsored by Universitätsklinikum Greifswald. Primary endpoint: Area under the curve. Started Sep 2011; status: completed.
02
Drugs
dapsone
03
Conditions
autoimmune bullous dermatosesLinear IgA bullous dermatosis (LABD)
Beyond the preview
Go deeper on NCT02493283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493283.